Whole exome-seq and RNA-seq data reveal unique neoantigen profiles in Kenyan breast cancer patients

Abstract

The unique neoantigen profiles in our patient group highlight the potential of immunotherapy in personalized breast cancer treatment as well as potential biomarkers for prognosis. The unique mutations producing these neoantigens, compared to other populations, provide an opportunity for validation in a much larger sample cohort.